Adherex Reports Meeting with FDA on Drug to Prevent Ototoxicity
Adherex Technologies Inc has announced that it is meeting with the FDAs Pediatric Subcommittee of the Oncologic Drugs Advisory Committee to discuss the development of Sodium Thiosulfate Injection, USP, 25% (STS) on November 1, 2011.
Read More